Clarus Lifesciences III is a Venture Capital Fund in Massachusetts with $342.64 mm assets under management, with a minimum investment of $5.00 mm. It has 34 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$342.64 mm
Address
Clarus Lifesciences III
101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA 02142
101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA 02142
Phone
617-949-2200
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Clarus Ventures, LLC | $1.59 bn | |
Clarus De II, L.P. | $25.82 mm | Venture Capital Fund |
Clarus Defined Exit I, L.P. | $63.05 mm | Venture Capital Fund |
Clarus Iv-a, L.P. | $336.55 mm | Venture Capital Fund |
Clarus Iv-b, L.P. | $218.42 mm | Venture Capital Fund |
Clarus Iv-c, L.P. | $402.80 mm | Venture Capital Fund |
Clarus Iv-d, L.P. | $80.61 mm | Venture Capital Fund |
Clarus Lifesciences I, L.P. | $63.02 mm | Venture Capital Fund |
Clarus Lifesciences II, L.P. | $55.67 mm | Venture Capital Fund |
Clarus Lifesciences III, L.P. | $342.64 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13D/A
Imago BioSciences, Inc.
12 Jan 23
4
STEPHEN A SCHWARZMAN
1 Apr 22
SC 13D/A
Imago BioSciences, Inc.
1 Apr 22
SC 13D/A
ESSA Pharma Inc.
12 Jan 22
SC 13D
Imago BioSciences, Inc.
30 Jul 21
4
STEPHEN A SCHWARZMAN
20 Jul 21
3
STEPHEN A SCHWARZMAN
15 Jul 21
4
Praxis Precision Medicines, Inc.
14 May 21
4
STEPHEN A SCHWARZMAN
14 May 21
3
STEPHEN A SCHWARZMAN
6 May 21